COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

South Korea’s Celltrion has joined the many pharma companies fighting the COVID-19 coronavirus outbreak, saying it is working on an antibody-based antiviral and a self-testing diagnosis kit ...

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...

New research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking ...

A fainter line will probably take longer to show up because it's taking more time for the antibodies to match with pieces of the virus. No COVID test can tell you for sure how long your illness ...

influenza B or the virus that causes COVID-19. The antibodies for these viral targets are placed on the strip, and when someone's nasal sample has viral proteins that are applied to the test strip ...

More than 70% of people with mild or moderate COVID develop certain antibodies in their nasal cavities that are linked to ...

It provides a more precise prediction than currently available of how serious the case is by focusing on autoantibodies in ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

Earlier this month, the Food and Drug Administration authorized the Healgen Scientific's Rapid Check COVID-19/Flu A&B Antigen Test for home use without a prescription, which makes it easier for ...

A new nasal swab test could predict how severe COVID-19 will be for a person. A study by Emory University found that by using nasal swabs, researchers could see which people developed COVID-19 ...